Get startedLog in
    Picture of Kiniksa Pharmaceuticals International logo

    KNSA — Kiniksa Pharmaceuticals International News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Brief: Kiniksa Pharmaceuticals Q3 EPS USD -0.2

    Picture of Kiniksa Pharmaceuticals International logoKiniksa Pharmaceuticals International
    31/10/2023 11:30
    Oct 31 (Reuters) - Kiniksa Pharmaceuticals Q3 pretax profit USD -8.499
million.
* Q3 net income USD -14.125 million
* Q3 product revenue USD 64.802 million
* Q3 operating expenses USD 77.973 million

    Recent news on Kiniksa Pharmaceuticals International

    See all news